# Cancer Prevention and Control

> **NIH NIH P30** · RUTGERS BIOMEDICAL AND HEALTH SCIENCES · 2024 · $9,429

## Abstract

CANCER PREVENTION AND CONTROL PROGRAM
PROJECT SUMMARY/ABSTRACT
The overarching goal of the Cancer Prevention and Control (CPC) Program is to advance population research
that elucidates and addresses Catchment Area (CA) cancer risks and outcomes, thus potentiating the impact of
translational research via collaboration among diverse faculty, trainees, and communities towards cancer health
equity. CPC utilizes CA resources (e.g., the NJ State Cancer Registry that is administered by CINJ, RWJBH
integrated health system) to identify and understand risk factors and outcome trajectories at multiple levels.
Members develop, evaluate, and inform implementation of interventions, strategies, guidelines, and policies to
address these risks, reduce cancer burden, and improve outcomes. Aligning with CINJ’s strategic plan and
catchment area priorities, CPC’s research falls into three major areas: 1) cancer epidemiology research that
evaluates multi-level factors (e.g., social determinants of health, neighborhood built environment, lifestyle and
biological factors) as predictors of racial and ethnic disparities in cancer risk, treatment, patient-reported
outcomes, and survival; 2) research designed to understand tobacco use and inform implementation of effective
tobacco control strategies; and 3) behavioral sciences research that elucidates and mitigates cancer risk, and
improves prevention and screening behaviors, as well as quality of life and other cancer outcomes through
theoretically-informed individual-, family-, system-level, and technology-based interventions and implementation
science. Since the last review, CPC has experienced considerable growth in expertise, funding, and
collaborations, with novel research findings and direct sustained public health impact. CPC currently has 58
members conducting cancer prevention and control research in 17 departments across seven schools in two
universities. In the current funding period, CPC members are highly productive, and collaborative as shown by
its 729 cancer-focused research publications, of which 33% are intraprogrammatic, 20% interprogrammatic, and
79% multi-institutional. CPC funding has also substantially increased by 67%, with a current research portfolio
of $10.2 million (annual direct costs) in cancer-relevant grant projects, with $6.9 million (direct costs) from NCI.
CPC is led by senior investigators with complementary expertise and distinct roles in leading the Program, Drs.
Elisa Bandera (epidemiology) and Carolyn Heckman (behavioral sciences). The Program benefits from diverse
expertise and transdisciplinary collaborations across the cancer continuum including prevention, survivorship,
health equity, care delivery and coordination, and tobacco control, as well as a strong record of mentoring the
next generation of diverse researchers in these areas. CPC research is invoked by bidirectional communication
with the Community Outreach and Engagement team and community to address CA needs that also ...

## Key facts

- **NIH application ID:** 10767723
- **Project number:** 2P30CA072720-25
- **Recipient organization:** RUTGERS BIOMEDICAL AND HEALTH SCIENCES
- **Principal Investigator:** Elisa V Bandera
- **Activity code:** P30 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2024
- **Award amount:** $9,429
- **Award type:** 2
- **Project period:** 1997-03-01 → 2029-02-28

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10767723

## Citation

> US National Institutes of Health, RePORTER application 10767723, Cancer Prevention and Control (2P30CA072720-25). Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/grant/nih/10767723. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*